1. Merck to buy Pandion for $1.9B for its immune modulators — Biden looking beyond Woodcock or Sharfstein for FDA commmisioner — Former AveXis execs launch gene therapy startup See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice

Restricted Stock

Discussion in 'Exact Sciences' started by Anonymous, Mar 13, 2015 at 6:17 PM.

  1. Anonymous

    Anonymous Guest

    Exact Sciences Grants Inducement Restricted Stock Unit Awards to New Employees
    By
    Published: Mar 13, 2015 4:00 p.m. ET

    SHARE

    MADISON, Wis., Mar 13, 2015 (BUSINESS WIRE) -- Exact Sciences Corp. EXAS, +0.00% today announced that, in support of the Company's continued growth plans, it has issued restricted stock units covering a total of 125,661 shares of common stock to 166 new non-executive employees under its previously announced inducement grant program. The restricted stock unit awards vest in four equal annual installments beginning on the first anniversary of the grant date. The Company is making this announcement as required by NASDAQ rules.

    About Exact Sciences

    Exact Sciences Corp. EXAS, +0.00% is a molecular diagnostics company focused on the early detection and prevention of colorectal cancer. The company has exclusive intellectual property protecting its noninvasive, molecular screening technology for the detection of colorectal cancer. Cologuard is included in the colorectal cancer screening guidelines of the American Cancer Society and stool DNA is included in the U.S. Multi-Society Task Force on Colorectal Cancer. For more information, please visit the company's website at www.exactsciences.com, follow us on Twitter @ExactSciences or find us on Facebook.
     
  2. Anonymous

    Anonymous Guest

    Been here before and the company actually made money. Unless you're early entry or top brass this is a carrot on a stick for us donkeys. Good selling.